Complementary and alternative medicine for the allergist-immunologist: Where do I start?
Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 200...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2009-02, Vol.123 (2), p.309-316.e4 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 316.e4 |
---|---|
container_issue | 2 |
container_start_page | 309 |
container_title | Journal of allergy and clinical immunology |
container_volume | 123 |
creator | Engler, Renata J.M., MD, FAAAAI, FACAAI With, Catherine M., JD, LLM, LLM Gregory, Philip J., PharmD Jellin, Jeff M., PharmD |
description | Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research. |
doi_str_mv | 10.1016/j.jaci.2009.01.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1504810623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674909000049</els_id><sourcerecordid>3239287941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7rj6BTxIQDx2W5X-GxFFhl1dWPCgoreQSardtN2dMcks7Lc3zQwuePAUinqvUvV7jD1HKBGwfT2WozauFACyBCwB8AHbIMiuaHvRPGSb3MCi7Wp5xp7EOEKuq14-ZmcoBVRtU2_Yj62f9xPNtCQd7rheLNdTorDo5G6Jz2SdcQvxwQeebig3Jwo_XUyFm-fD4ie_Fm_49xsKxK3nVzzmSen9U_Zo0FOkZ6f3nH27vPi6_VRcf_54tf1wXZgGMRV1RQDaNn2NbU-DlZ0WxiI2lW5rsEI0QmCPpGUrOqsRWmMt7TQMOxhqlNU5e3mcuw_-94FiUqM_5PWnqLCBus8OUWWVOKpM8DEGGtQ-uDlfrBDUClONaoWpVpgKUGWY2fTiNPqwyyDuLSd6WfDqJNDR6GkIejEu_tUJRNF2fZN1b486yiBuHQUVjaPFZLiBTFLWu__v8e4fu5nc4vKPv-iO4v29KgoF6ssa-5o6yJw41LL6AyjHprM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504810623</pqid></control><display><type>article</type><title>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Engler, Renata J.M., MD, FAAAAI, FACAAI ; With, Catherine M., JD, LLM, LLM ; Gregory, Philip J., PharmD ; Jellin, Jeff M., PharmD</creator><creatorcontrib>Engler, Renata J.M., MD, FAAAAI, FACAAI ; With, Catherine M., JD, LLM, LLM ; Gregory, Philip J., PharmD ; Jellin, Jeff M., PharmD</creatorcontrib><description>Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2009.01.001</identifier><identifier>PMID: 19203654</identifier><identifier>CODEN: JACIBY</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>adverse reactions ; Allergy and Immunology ; Alternative medicine ; Bias ; Biological and medical sciences ; Biological Products - adverse effects ; Biological Products - therapeutic use ; Clinical trials ; Complementary and alternative medicine ; Complementary Therapies - adverse effects ; Complementary Therapies - ethics ; Complementary Therapies - legislation & jurisprudence ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Health Personnel - ethics ; Health Services Needs and Demand - ethics ; Health Services Needs and Demand - legislation & jurisprudence ; Herb-Drug Interactions ; herbals ; herbs ; Humans ; Hypersensitivity - immunology ; Hypersensitivity - therapy ; integrative medicine ; Medical sciences ; Meetings ; Patients ; Physicians ; Plant Preparations - adverse effects ; Plant Preparations - therapeutic use ; Plants, Medicinal ; quality of care ; Quality of life ; Ratings & rankings ; risk communication ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Studies ; Treatment Outcome ; Validity</subject><ispartof>Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.309-316.e4</ispartof><rights>American Academy of Allergy, Asthma & Immunology</rights><rights>2009 American Academy of Allergy, Asthma & Immunology</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Feb 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</citedby><cites>FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2009.01.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21126785$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19203654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Engler, Renata J.M., MD, FAAAAI, FACAAI</creatorcontrib><creatorcontrib>With, Catherine M., JD, LLM, LLM</creatorcontrib><creatorcontrib>Gregory, Philip J., PharmD</creatorcontrib><creatorcontrib>Jellin, Jeff M., PharmD</creatorcontrib><title>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.</description><subject>adverse reactions</subject><subject>Allergy and Immunology</subject><subject>Alternative medicine</subject><subject>Bias</subject><subject>Biological and medical sciences</subject><subject>Biological Products - adverse effects</subject><subject>Biological Products - therapeutic use</subject><subject>Clinical trials</subject><subject>Complementary and alternative medicine</subject><subject>Complementary Therapies - adverse effects</subject><subject>Complementary Therapies - ethics</subject><subject>Complementary Therapies - legislation & jurisprudence</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Health Personnel - ethics</subject><subject>Health Services Needs and Demand - ethics</subject><subject>Health Services Needs and Demand - legislation & jurisprudence</subject><subject>Herb-Drug Interactions</subject><subject>herbals</subject><subject>herbs</subject><subject>Humans</subject><subject>Hypersensitivity - immunology</subject><subject>Hypersensitivity - therapy</subject><subject>integrative medicine</subject><subject>Medical sciences</subject><subject>Meetings</subject><subject>Patients</subject><subject>Physicians</subject><subject>Plant Preparations - adverse effects</subject><subject>Plant Preparations - therapeutic use</subject><subject>Plants, Medicinal</subject><subject>quality of care</subject><subject>Quality of life</subject><subject>Ratings & rankings</subject><subject>risk communication</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Studies</subject><subject>Treatment Outcome</subject><subject>Validity</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-LFDEQxYMo7rj6BTxIQDx2W5X-GxFFhl1dWPCgoreQSardtN2dMcks7Lc3zQwuePAUinqvUvV7jD1HKBGwfT2WozauFACyBCwB8AHbIMiuaHvRPGSb3MCi7Wp5xp7EOEKuq14-ZmcoBVRtU2_Yj62f9xPNtCQd7rheLNdTorDo5G6Jz2SdcQvxwQeebig3Jwo_XUyFm-fD4ie_Fm_49xsKxK3nVzzmSen9U_Zo0FOkZ6f3nH27vPi6_VRcf_54tf1wXZgGMRV1RQDaNn2NbU-DlZ0WxiI2lW5rsEI0QmCPpGUrOqsRWmMt7TQMOxhqlNU5e3mcuw_-94FiUqM_5PWnqLCBus8OUWWVOKpM8DEGGtQ-uDlfrBDUClONaoWpVpgKUGWY2fTiNPqwyyDuLSd6WfDqJNDR6GkIejEu_tUJRNF2fZN1b486yiBuHQUVjaPFZLiBTFLWu__v8e4fu5nc4vKPv-iO4v29KgoF6ssa-5o6yJw41LL6AyjHprM</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Engler, Renata J.M., MD, FAAAAI, FACAAI</creator><creator>With, Catherine M., JD, LLM, LLM</creator><creator>Gregory, Philip J., PharmD</creator><creator>Jellin, Jeff M., PharmD</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20090201</creationdate><title>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</title><author>Engler, Renata J.M., MD, FAAAAI, FACAAI ; With, Catherine M., JD, LLM, LLM ; Gregory, Philip J., PharmD ; Jellin, Jeff M., PharmD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-43e00ad584168efd97a2cd1153a640d22522181ea9627da106cddeba0fb0f4193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>adverse reactions</topic><topic>Allergy and Immunology</topic><topic>Alternative medicine</topic><topic>Bias</topic><topic>Biological and medical sciences</topic><topic>Biological Products - adverse effects</topic><topic>Biological Products - therapeutic use</topic><topic>Clinical trials</topic><topic>Complementary and alternative medicine</topic><topic>Complementary Therapies - adverse effects</topic><topic>Complementary Therapies - ethics</topic><topic>Complementary Therapies - legislation & jurisprudence</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Health Personnel - ethics</topic><topic>Health Services Needs and Demand - ethics</topic><topic>Health Services Needs and Demand - legislation & jurisprudence</topic><topic>Herb-Drug Interactions</topic><topic>herbals</topic><topic>herbs</topic><topic>Humans</topic><topic>Hypersensitivity - immunology</topic><topic>Hypersensitivity - therapy</topic><topic>integrative medicine</topic><topic>Medical sciences</topic><topic>Meetings</topic><topic>Patients</topic><topic>Physicians</topic><topic>Plant Preparations - adverse effects</topic><topic>Plant Preparations - therapeutic use</topic><topic>Plants, Medicinal</topic><topic>quality of care</topic><topic>Quality of life</topic><topic>Ratings & rankings</topic><topic>risk communication</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Studies</topic><topic>Treatment Outcome</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Engler, Renata J.M., MD, FAAAAI, FACAAI</creatorcontrib><creatorcontrib>With, Catherine M., JD, LLM, LLM</creatorcontrib><creatorcontrib>Gregory, Philip J., PharmD</creatorcontrib><creatorcontrib>Jellin, Jeff M., PharmD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Engler, Renata J.M., MD, FAAAAI, FACAAI</au><au>With, Catherine M., JD, LLM, LLM</au><au>Gregory, Philip J., PharmD</au><au>Jellin, Jeff M., PharmD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complementary and alternative medicine for the allergist-immunologist: Where do I start?</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>123</volume><issue>2</issue><spage>309</spage><epage>316.e4</epage><pages>309-316.e4</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><coden>JACIBY</coden><abstract>Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19203654</pmid><doi>10.1016/j.jaci.2009.01.001</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.309-316.e4 |
issn | 0091-6749 1097-6825 |
language | eng |
recordid | cdi_proquest_journals_1504810623 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | adverse reactions Allergy and Immunology Alternative medicine Bias Biological and medical sciences Biological Products - adverse effects Biological Products - therapeutic use Clinical trials Complementary and alternative medicine Complementary Therapies - adverse effects Complementary Therapies - ethics Complementary Therapies - legislation & jurisprudence Fundamental and applied biological sciences. Psychology Fundamental immunology Health Personnel - ethics Health Services Needs and Demand - ethics Health Services Needs and Demand - legislation & jurisprudence Herb-Drug Interactions herbals herbs Humans Hypersensitivity - immunology Hypersensitivity - therapy integrative medicine Medical sciences Meetings Patients Physicians Plant Preparations - adverse effects Plant Preparations - therapeutic use Plants, Medicinal quality of care Quality of life Ratings & rankings risk communication Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Studies Treatment Outcome Validity |
title | Complementary and alternative medicine for the allergist-immunologist: Where do I start? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T12%3A35%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complementary%20and%20alternative%20medicine%20for%20the%20allergist-immunologist:%20Where%20do%20I%20start?&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Engler,%20Renata%20J.M.,%20MD,%20FAAAAI,%20FACAAI&rft.date=2009-02-01&rft.volume=123&rft.issue=2&rft.spage=309&rft.epage=316.e4&rft.pages=309-316.e4&rft.issn=0091-6749&rft.eissn=1097-6825&rft.coden=JACIBY&rft_id=info:doi/10.1016/j.jaci.2009.01.001&rft_dat=%3Cproquest_cross%3E3239287941%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504810623&rft_id=info:pmid/19203654&rft_els_id=1_s2_0_S0091674909000049&rfr_iscdi=true |